The analysis of the expression of hormone receptors in meningiomas, therefore, appears to be necessary for future pre-therapeutic analysis in targeted hormonal therapy, for which a target reference population needs to be defined in large prospective clinical studies. The gene discussed is NR4A1; the disease is meningioma.